SLCO1B1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S293-p
PQKERKAsLsLHVLE
0 2
SLCO1B1 (human) PQKERKAsLsLHVLE S293-p
S295-p
KERKAsLsLHVLEtN
0 2
SLCO1B1 (human) KERKAsLsLHVLEtN S295-p
T301-p
LsLHVLEtNDEKDQT
0 1
SLCO1B1 (human) LsLHVLEtNDEKDQT T301-p
T319-p
TNQGKNItKNVtGFF
0 1
SLCO1B1 (human) TNQGKNItKNVtGFF T319-p
T323-p
KNItKNVtGFFQsFK
0 1
SLCO1B1 (human) KNItKNVtGFFQsFK T323-p
S328-p
NVtGFFQsFKSILTN
0 1
SLCO1B1 (human) NVtGFFQsFKSILTN S328-p
Y367-p
FKYVEQQyGQPSSKA
0 1
SLCO1B1 (human) FKYVEQQyGQPSSKA Y367-p
S420-p
FTAVMSLsFyLLyFF
0 1
SLCO1B1 (human) FTAVMSLsFyLLyFF S420-p
Y422-p
AVMSLsFyLLyFFIL
0 1
SLCO1B1 (human) AVMSLsFyLLyFFIL Y422-p
Y425-p
SLsFyLLyFFILCEN
0 1
SLCO1B1 (human) SLsFyLLyFFILCEN Y425-p
Y625-p
STSFSRVyLGLSSML
0 1
SLCO1B1 (human) STSFSRVyLGLSSML Y625-p
S636-p
SSMLRVSsLVLyIIL
0 2
SLCO1B1 (human) SSMLRVSsLVLyIIL S636-p
Y640-p
RVSsLVLyIILIyAM
Upstream
Downstream
1 1
Effects on Modified Protein
  • activity, induced
Treatment
  • nilotinib
SLCO1B1 (human) RVSsLVLyIILIyAM Y640-p
Y645-p
VLyIILIyAMKKKYQ
Upstream
Downstream
1 2
Effects on Modified Protein
  • activity, induced
Putative in vivo kinases:
  • LYN (human)
Treatment
  • nilotinib
  • siRNA
SLCO1B1 (human) VLyIILIyAMKKKYQ Y645-p
S659-p
QEKDINAsENGsVMD
0 2
SLCO1B1 (human) QEKDINAsENGsVMD S659-p
S663-p
INAsENGsVMDEANL
0 1
SLCO1B1 (human) INAsENGsVMDEANL S663-p
S672-p
MDEANLEsLNKNKHF
0 1
SLCO1B1 (human) MDEANLEsLNKNKHF S672-p
S682-p
KNKHFVPsAGADsEt
0 2
SLCO1B1 (human) KNKHFVPsAGADsEt S682-p
S687-p
VPsAGADsEtHC___
0 2
SLCO1B1 (human) VPsAGADsEtHC___ S687-p
T689-p
sAGADsEtHC_____
0 1
SLCO1B1 (human) sAGADsEtHC_____ T689-p